FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.1  |  FHIR Version n/a  User: [n/a]

32970411000001106: Odefsey 200mg/25mg/25mg tablets (Gilead Sciences Ltd) 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Aug 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1526181000001115 Odefsey 200mg/25mg/25mg tablets (Gilead Sciences Ireland UC) 30 tablet en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
1526191000001118 Odefsey 200mg/25mg/25mg tablets (Gilead Sciences Ireland UC) 30 tablet (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
1842291000001111 Odefsey 200mg/25mg/25mg tablets (Gilead Sciences Ltd) 30 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1842301000001110 Odefsey 200mg/25mg/25mg tablets (Gilead Sciences Ltd) 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
100477101000001116 Odefsey 200mg/25mg/25mg tablets (Gilead Sciences International Ltd) 30 tablet (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
100477201000001111 Odefsey 200mg/25mg/25mg tablets (Gilead Sciences International Ltd) 30 tablet en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Odefsey 200mg/25mg/25mg tablets (Gilead Sciences Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Odefsey 200mg/25mg/25mg tablets (Gilead Sciences Ltd) 30 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Odefsey 200mg/25mg/25mg tablets (Gilead Sciences Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Odefsey 200mg/25mg/25mg tablets (Gilead Sciences Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring false Inferred relationship Existential restriction modifier
Odefsey 200mg/25mg/25mg tablets (Gilead Sciences Ltd) 30 tablet Is a Generic Odefsey 200mg/25mg/25mg tablets 30 tablet true Inferred relationship Existential restriction modifier
Odefsey 200mg/25mg/25mg tablets (Gilead Sciences Ltd) 30 tablet Has AMP Odefsey 200mg/25mg/25mg tablets (Gilead Sciences Ltd) true Inferred relationship Existential restriction modifier
Odefsey 200mg/25mg/25mg tablets (Gilead Sciences Ltd) 30 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Odefsey 200mg/25mg/25mg tablets (Gilead Sciences Ltd) 30 tablet Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Odefsey 200mg/25mg/25mg tablets (Gilead Sciences Ltd) 30 tablet VMP prescribing status (attribute) Never valid to prescribe as a VMP true Inferred relationship Existential restriction modifier
Odefsey 200mg/25mg/25mg tablets (Gilead Sciences Ltd) 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Odefsey 200mg/25mg/25mg tablets (Gilead Sciences Ltd) 30 tablet Has specific active ingredient Emtricitabine true Inferred relationship Existential restriction modifier
Odefsey 200mg/25mg/25mg tablets (Gilead Sciences Ltd) 30 tablet Has specific active ingredient Rilpivirine hydrochloride true Inferred relationship Existential restriction modifier
Odefsey 200mg/25mg/25mg tablets (Gilead Sciences Ltd) 30 tablet Has specific active ingredient Tenofovir alafenamide fumarate false Inferred relationship Existential restriction modifier
Odefsey 200mg/25mg/25mg tablets (Gilead Sciences Ltd) 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Odefsey 200mg/25mg/25mg tablets (Gilead Sciences Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Rilpivirine true Inferred relationship Existential restriction modifier
Odefsey 200mg/25mg/25mg tablets (Gilead Sciences Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Tenofovir alafenamide false Inferred relationship Existential restriction modifier
Odefsey 200mg/25mg/25mg tablets (Gilead Sciences Ltd) 30 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Odefsey 200mg/25mg/25mg tablets (Gilead Sciences Ltd) 30 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Odefsey 200mg/25mg/25mg tablets (Gilead Sciences Ltd) 30 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Odefsey 200mg/25mg/25mg tablets (Gilead Sciences Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Tenofovir alafenamide true Inferred relationship Existential restriction modifier
Odefsey 200mg/25mg/25mg tablets (Gilead Sciences Ltd) 30 tablet Has basis of strength substance Rilpivirine true Inferred relationship Existential restriction modifier
Odefsey 200mg/25mg/25mg tablets (Gilead Sciences Ltd) 30 tablet Has basis of strength substance Tenofovir alafenamide true Inferred relationship Existential restriction modifier
Odefsey 200mg/25mg/25mg tablets (Gilead Sciences Ltd) 30 tablet Has specific active ingredient Tenofovir alafenamide fumarate true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start